nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Ezetimibe—atherosclerosis	0.152	0.201	CbGbCtD
Levetiracetam—ABCC2—Simvastatin—atherosclerosis	0.141	0.187	CbGbCtD
Levetiracetam—ABCC2—Lovastatin—atherosclerosis	0.138	0.183	CbGbCtD
Levetiracetam—ABCC2—Pravastatin—atherosclerosis	0.138	0.183	CbGbCtD
Levetiracetam—ABCB1—Ezetimibe—atherosclerosis	0.0495	0.0656	CbGbCtD
Levetiracetam—ABCB1—Simvastatin—atherosclerosis	0.046	0.061	CbGbCtD
Levetiracetam—ABCB1—Pravastatin—atherosclerosis	0.045	0.0597	CbGbCtD
Levetiracetam—ABCB1—Lovastatin—atherosclerosis	0.045	0.0597	CbGbCtD
Levetiracetam—ABCC2—Irinotecan Pathway—NPC1—atherosclerosis	0.00459	0.163	CbGpPWpGaD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.00148	0.0526	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCG4—atherosclerosis	0.00118	0.042	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCG8—atherosclerosis	0.00113	0.0403	CbGpPWpGaD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—GJA4—atherosclerosis	0.00107	0.0381	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000936	0.0333	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCG1—atherosclerosis	0.000895	0.0318	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000849	0.0302	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000735	0.0262	CbGpPWpGaD
Levetiracetam—Nasopharyngitis—Pravastatin—atherosclerosis	0.000714	0.00329	CcSEcCtD
Levetiracetam—Infestation NOS—Ezetimibe—atherosclerosis	0.000714	0.00328	CcSEcCtD
Levetiracetam—Infestation—Ezetimibe—atherosclerosis	0.000714	0.00328	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000709	0.00326	CcSEcCtD
Levetiracetam—Urinary tract infection—Lovastatin—atherosclerosis	0.000707	0.00325	CcSEcCtD
Levetiracetam—Muscular weakness—Pravastatin—atherosclerosis	0.000704	0.00324	CcSEcCtD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCG5—atherosclerosis	0.000702	0.025	CbGpPWpGaD
Levetiracetam—Influenza—Niacin—atherosclerosis	0.000701	0.00323	CcSEcCtD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.000695	0.0247	CbGpPWpGaD
Levetiracetam—Influenza—Pravastatin—atherosclerosis	0.00069	0.00318	CcSEcCtD
Levetiracetam—Eosinophilia—Pravastatin—atherosclerosis	0.000683	0.00314	CcSEcCtD
Levetiracetam—Sinusitis—Lovastatin—atherosclerosis	0.000683	0.00314	CcSEcCtD
Levetiracetam—Depression—Simvastatin—atherosclerosis	0.000679	0.00312	CcSEcCtD
Levetiracetam—Pancreatitis—Pravastatin—atherosclerosis	0.000677	0.00311	CcSEcCtD
Levetiracetam—Mental disorder—Rosuvastatin—atherosclerosis	0.000675	0.00311	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000675	0.00311	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000675	0.00311	CcSEcCtD
Levetiracetam—Bronchitis—Niacin—atherosclerosis	0.000674	0.0031	CcSEcCtD
Levetiracetam—Sinusitis—Ezetimibe—atherosclerosis	0.00067	0.00308	CcSEcCtD
Levetiracetam—Hepatitis—Lovastatin—atherosclerosis	0.000653	0.00301	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000641	0.00295	CcSEcCtD
Levetiracetam—Hepatitis—Ezetimibe—atherosclerosis	0.000641	0.00295	CcSEcCtD
Levetiracetam—Sinusitis—Simvastatin—atherosclerosis	0.000639	0.00294	CcSEcCtD
Levetiracetam—Pharyngitis—Ezetimibe—atherosclerosis	0.000636	0.00293	CcSEcCtD
Levetiracetam—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00063	0.0029	CcSEcCtD
Levetiracetam—Weight increased—Pravastatin—atherosclerosis	0.000628	0.00289	CcSEcCtD
Levetiracetam—Weight decreased—Pravastatin—atherosclerosis	0.000624	0.00287	CcSEcCtD
Levetiracetam—Erythema multiforme—Lovastatin—atherosclerosis	0.000618	0.00284	CcSEcCtD
Levetiracetam—Depression—Pravastatin—atherosclerosis	0.000614	0.00282	CcSEcCtD
Levetiracetam—Hepatitis—Simvastatin—atherosclerosis	0.000611	0.00281	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00061	0.00281	CcSEcCtD
Levetiracetam—Stomatitis—Niacin—atherosclerosis	0.000609	0.0028	CcSEcCtD
Levetiracetam—Erythema multiforme—Ezetimibe—atherosclerosis	0.000606	0.00279	CcSEcCtD
Levetiracetam—Urinary tract infection—Pravastatin—atherosclerosis	0.000598	0.00275	CcSEcCtD
Levetiracetam—Cough—Rosuvastatin—atherosclerosis	0.000586	0.00269	CcSEcCtD
Levetiracetam—Immune system disorder—Ezetimibe—atherosclerosis	0.000579	0.00266	CcSEcCtD
Levetiracetam—Erythema multiforme—Simvastatin—atherosclerosis	0.000578	0.00266	CcSEcCtD
Levetiracetam—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000577	0.00266	CcSEcCtD
Levetiracetam—Sinusitis—Pravastatin—atherosclerosis	0.000577	0.00266	CcSEcCtD
Levetiracetam—Alopecia—Lovastatin—atherosclerosis	0.000577	0.00266	CcSEcCtD
Levetiracetam—Arthralgia—Rosuvastatin—atherosclerosis	0.000571	0.00263	CcSEcCtD
Levetiracetam—Myalgia—Rosuvastatin—atherosclerosis	0.000571	0.00263	CcSEcCtD
Levetiracetam—Alopecia—Ezetimibe—atherosclerosis	0.000566	0.00261	CcSEcCtD
Levetiracetam—Rhinitis—Niacin—atherosclerosis	0.000562	0.00259	CcSEcCtD
Levetiracetam—Mental disorder—Ezetimibe—atherosclerosis	0.000561	0.00258	CcSEcCtD
Levetiracetam—Hepatitis—Niacin—atherosclerosis	0.000561	0.00258	CcSEcCtD
Levetiracetam—Malnutrition—Ezetimibe—atherosclerosis	0.000558	0.00257	CcSEcCtD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—ABCG4—atherosclerosis	0.000555	0.0198	CbGpPWpGaD
Levetiracetam—Rhinitis—Pravastatin—atherosclerosis	0.000554	0.00255	CcSEcCtD
Levetiracetam—Hepatitis—Pravastatin—atherosclerosis	0.000552	0.00254	CcSEcCtD
Levetiracetam—Confusional state—Rosuvastatin—atherosclerosis	0.000552	0.00254	CcSEcCtD
Levetiracetam—Back pain—Lovastatin—atherosclerosis	0.00055	0.00253	CcSEcCtD
Levetiracetam—Pharyngitis—Pravastatin—atherosclerosis	0.000548	0.00252	CcSEcCtD
Levetiracetam—Infection—Rosuvastatin—atherosclerosis	0.000544	0.0025	CcSEcCtD
Levetiracetam—Alopecia—Simvastatin—atherosclerosis	0.00054	0.00248	CcSEcCtD
Levetiracetam—Back pain—Ezetimibe—atherosclerosis	0.00054	0.00248	CcSEcCtD
Levetiracetam—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000537	0.00247	CcSEcCtD
Levetiracetam—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000536	0.00247	CcSEcCtD
Levetiracetam—Vision blurred—Lovastatin—atherosclerosis	0.000536	0.00247	CcSEcCtD
Levetiracetam—Mental disorder—Simvastatin—atherosclerosis	0.000535	0.00246	CcSEcCtD
Levetiracetam—Tremor—Lovastatin—atherosclerosis	0.000533	0.00245	CcSEcCtD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—ABCG8—atherosclerosis	0.000532	0.0189	CbGpPWpGaD
Levetiracetam—Eye disorder—Niacin—atherosclerosis	0.000524	0.00241	CcSEcCtD
Levetiracetam—Erythema multiforme—Pravastatin—atherosclerosis	0.000522	0.0024	CcSEcCtD
Levetiracetam—Vertigo—Lovastatin—atherosclerosis	0.000511	0.00235	CcSEcCtD
Levetiracetam—Leukopenia—Lovastatin—atherosclerosis	0.000509	0.00234	CcSEcCtD
Levetiracetam—Vision blurred—Simvastatin—atherosclerosis	0.000501	0.00231	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000499	0.0023	CcSEcCtD
Levetiracetam—Tremor—Simvastatin—atherosclerosis	0.000498	0.00229	CcSEcCtD
Levetiracetam—Alopecia—Niacin—atherosclerosis	0.000496	0.00228	CcSEcCtD
Levetiracetam—Insomnia—Rosuvastatin—atherosclerosis	0.000495	0.00228	CcSEcCtD
Levetiracetam—Paraesthesia—Rosuvastatin—atherosclerosis	0.000492	0.00226	CcSEcCtD
Levetiracetam—Malnutrition—Niacin—atherosclerosis	0.000488	0.00225	CcSEcCtD
Levetiracetam—Alopecia—Pravastatin—atherosclerosis	0.000488	0.00225	CcSEcCtD
Levetiracetam—Cough—Ezetimibe—atherosclerosis	0.000487	0.00224	CcSEcCtD
Levetiracetam—Arthralgia—Lovastatin—atherosclerosis	0.000484	0.00223	CcSEcCtD
Levetiracetam—Myalgia—Lovastatin—atherosclerosis	0.000484	0.00223	CcSEcCtD
Levetiracetam—Chest pain—Lovastatin—atherosclerosis	0.000484	0.00223	CcSEcCtD
Levetiracetam—Anxiety—Lovastatin—atherosclerosis	0.000482	0.00222	CcSEcCtD
Levetiracetam—Dyspepsia—Rosuvastatin—atherosclerosis	0.000482	0.00222	CcSEcCtD
Levetiracetam—Tension—Niacin—atherosclerosis	0.000479	0.00221	CcSEcCtD
Levetiracetam—Vertigo—Simvastatin—atherosclerosis	0.000478	0.0022	CcSEcCtD
Levetiracetam—Leukopenia—Simvastatin—atherosclerosis	0.000476	0.00219	CcSEcCtD
Levetiracetam—Arthralgia—Ezetimibe—atherosclerosis	0.000475	0.00219	CcSEcCtD
Levetiracetam—Myalgia—Ezetimibe—atherosclerosis	0.000475	0.00219	CcSEcCtD
Levetiracetam—Chest pain—Ezetimibe—atherosclerosis	0.000475	0.00219	CcSEcCtD
Levetiracetam—Nervousness—Niacin—atherosclerosis	0.000474	0.00218	CcSEcCtD
Levetiracetam—Tension—Pravastatin—atherosclerosis	0.000472	0.00217	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000472	0.00217	CcSEcCtD
Levetiracetam—Constipation—Rosuvastatin—atherosclerosis	0.000468	0.00216	CcSEcCtD
Levetiracetam—Pain—Rosuvastatin—atherosclerosis	0.000468	0.00216	CcSEcCtD
Levetiracetam—Confusional state—Lovastatin—atherosclerosis	0.000468	0.00215	CcSEcCtD
Levetiracetam—Nervousness—Pravastatin—atherosclerosis	0.000467	0.00215	CcSEcCtD
Levetiracetam—Infection—Lovastatin—atherosclerosis	0.000461	0.00212	CcSEcCtD
Levetiracetam—Vision blurred—Niacin—atherosclerosis	0.00046	0.00212	CcSEcCtD
Levetiracetam—Confusional state—Ezetimibe—atherosclerosis	0.000459	0.00211	CcSEcCtD
Levetiracetam—Thrombocytopenia—Lovastatin—atherosclerosis	0.000454	0.00209	CcSEcCtD
Levetiracetam—Vision blurred—Pravastatin—atherosclerosis	0.000453	0.00209	CcSEcCtD
Levetiracetam—Myalgia—Simvastatin—atherosclerosis	0.000453	0.00208	CcSEcCtD
Levetiracetam—Chest pain—Simvastatin—atherosclerosis	0.000453	0.00208	CcSEcCtD
Levetiracetam—Arthralgia—Simvastatin—atherosclerosis	0.000453	0.00208	CcSEcCtD
Levetiracetam—Infection—Ezetimibe—atherosclerosis	0.000452	0.00208	CcSEcCtD
Levetiracetam—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000451	0.00208	CcSEcCtD
Levetiracetam—Anxiety—Simvastatin—atherosclerosis	0.000451	0.00208	CcSEcCtD
Levetiracetam—Tremor—Pravastatin—atherosclerosis	0.000451	0.00207	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000448	0.00206	CcSEcCtD
Levetiracetam—Nervous system disorder—Ezetimibe—atherosclerosis	0.000446	0.00205	CcSEcCtD
Levetiracetam—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000446	0.00205	CcSEcCtD
Levetiracetam—Anorexia—Lovastatin—atherosclerosis	0.000442	0.00204	CcSEcCtD
Levetiracetam—Skin disorder—Ezetimibe—atherosclerosis	0.000442	0.00203	CcSEcCtD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.00044	0.0157	CbGpPWpGaD
Levetiracetam—Vertigo—Niacin—atherosclerosis	0.000439	0.00202	CcSEcCtD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000438	0.0156	CbGpPWpGaD
Levetiracetam—Confusional state—Simvastatin—atherosclerosis	0.000438	0.00201	CcSEcCtD
Levetiracetam—Leukopenia—Niacin—atherosclerosis	0.000437	0.00201	CcSEcCtD
Levetiracetam—Abdominal pain—Rosuvastatin—atherosclerosis	0.000433	0.00199	CcSEcCtD
Levetiracetam—Vertigo—Pravastatin—atherosclerosis	0.000432	0.00199	CcSEcCtD
Levetiracetam—Infection—Simvastatin—atherosclerosis	0.000431	0.00198	CcSEcCtD
Levetiracetam—Leukopenia—Pravastatin—atherosclerosis	0.00043	0.00198	CcSEcCtD
Levetiracetam—Cough—Niacin—atherosclerosis	0.000426	0.00196	CcSEcCtD
Levetiracetam—Thrombocytopenia—Simvastatin—atherosclerosis	0.000425	0.00196	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000423	0.00195	CcSEcCtD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—ABCG1—atherosclerosis	0.000421	0.015	CbGpPWpGaD
Levetiracetam—Insomnia—Lovastatin—atherosclerosis	0.00042	0.00193	CcSEcCtD
Levetiracetam—Cough—Pravastatin—atherosclerosis	0.00042	0.00193	CcSEcCtD
Levetiracetam—Paraesthesia—Lovastatin—atherosclerosis	0.000417	0.00192	CcSEcCtD
Levetiracetam—Myalgia—Niacin—atherosclerosis	0.000416	0.00191	CcSEcCtD
Levetiracetam—Arthralgia—Niacin—atherosclerosis	0.000416	0.00191	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000415	0.00191	CcSEcCtD
Levetiracetam—Anorexia—Simvastatin—atherosclerosis	0.000414	0.0019	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000413	0.0019	CcSEcCtD
Levetiracetam—Insomnia—Ezetimibe—atherosclerosis	0.000412	0.00189	CcSEcCtD
Levetiracetam—Chest pain—Pravastatin—atherosclerosis	0.000409	0.00188	CcSEcCtD
Levetiracetam—Myalgia—Pravastatin—atherosclerosis	0.000409	0.00188	CcSEcCtD
Levetiracetam—Arthralgia—Pravastatin—atherosclerosis	0.000409	0.00188	CcSEcCtD
Levetiracetam—Paraesthesia—Ezetimibe—atherosclerosis	0.000409	0.00188	CcSEcCtD
Levetiracetam—Dyspepsia—Lovastatin—atherosclerosis	0.000409	0.00188	CcSEcCtD
Levetiracetam—Anxiety—Pravastatin—atherosclerosis	0.000408	0.00188	CcSEcCtD
Levetiracetam—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000403	0.00186	CcSEcCtD
Levetiracetam—Decreased appetite—Lovastatin—atherosclerosis	0.000403	0.00186	CcSEcCtD
Levetiracetam—Dyspepsia—Ezetimibe—atherosclerosis	0.000401	0.00184	CcSEcCtD
Levetiracetam—Fatigue—Lovastatin—atherosclerosis	0.0004	0.00184	CcSEcCtD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000399	0.0142	CbGpPWpGaD
Levetiracetam—Constipation—Lovastatin—atherosclerosis	0.000397	0.00183	CcSEcCtD
Levetiracetam—Pain—Lovastatin—atherosclerosis	0.000397	0.00183	CcSEcCtD
Levetiracetam—Confusional state—Pravastatin—atherosclerosis	0.000396	0.00182	CcSEcCtD
Levetiracetam—Decreased appetite—Ezetimibe—atherosclerosis	0.000396	0.00182	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000396	0.00182	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000393	0.00181	CcSEcCtD
Levetiracetam—Asthenia—Rosuvastatin—atherosclerosis	0.000393	0.00181	CcSEcCtD
Levetiracetam—Insomnia—Simvastatin—atherosclerosis	0.000393	0.00181	CcSEcCtD
Levetiracetam—Fatigue—Ezetimibe—atherosclerosis	0.000392	0.00181	CcSEcCtD
Levetiracetam—Infection—Pravastatin—atherosclerosis	0.00039	0.00179	CcSEcCtD
Levetiracetam—Paraesthesia—Simvastatin—atherosclerosis	0.00039	0.00179	CcSEcCtD
Levetiracetam—Constipation—Ezetimibe—atherosclerosis	0.000389	0.00179	CcSEcCtD
Levetiracetam—Pain—Ezetimibe—atherosclerosis	0.000389	0.00179	CcSEcCtD
Levetiracetam—Pruritus—Rosuvastatin—atherosclerosis	0.000387	0.00178	CcSEcCtD
Levetiracetam—Skin disorder—Niacin—atherosclerosis	0.000387	0.00178	CcSEcCtD
Levetiracetam—Thrombocytopenia—Pravastatin—atherosclerosis	0.000384	0.00177	CcSEcCtD
Levetiracetam—Feeling abnormal—Lovastatin—atherosclerosis	0.000382	0.00176	CcSEcCtD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—PRKCG—atherosclerosis	0.000382	0.0136	CbGpPWpGaD
Levetiracetam—Dyspepsia—Simvastatin—atherosclerosis	0.000382	0.00176	CcSEcCtD
Levetiracetam—Anorexia—Niacin—atherosclerosis	0.00038	0.00175	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00038	0.00175	CcSEcCtD
Levetiracetam—Decreased appetite—Simvastatin—atherosclerosis	0.000377	0.00174	CcSEcCtD
Levetiracetam—Feeling abnormal—Ezetimibe—atherosclerosis	0.000375	0.00173	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000375	0.00172	CcSEcCtD
Levetiracetam—Diarrhoea—Rosuvastatin—atherosclerosis	0.000375	0.00172	CcSEcCtD
Levetiracetam—Fatigue—Simvastatin—atherosclerosis	0.000374	0.00172	CcSEcCtD
Levetiracetam—Anorexia—Pravastatin—atherosclerosis	0.000374	0.00172	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000372	0.00171	CcSEcCtD
Levetiracetam—Constipation—Simvastatin—atherosclerosis	0.000371	0.00171	CcSEcCtD
Levetiracetam—Pain—Simvastatin—atherosclerosis	0.000371	0.00171	CcSEcCtD
Levetiracetam—Body temperature increased—Lovastatin—atherosclerosis	0.000367	0.00169	CcSEcCtD
Levetiracetam—Abdominal pain—Lovastatin—atherosclerosis	0.000367	0.00169	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000363	0.00167	CcSEcCtD
Levetiracetam—Dizziness—Rosuvastatin—atherosclerosis	0.000362	0.00167	CcSEcCtD
Levetiracetam—Insomnia—Niacin—atherosclerosis	0.000361	0.00166	CcSEcCtD
Levetiracetam—Abdominal pain—Ezetimibe—atherosclerosis	0.00036	0.00166	CcSEcCtD
Levetiracetam—Body temperature increased—Ezetimibe—atherosclerosis	0.00036	0.00166	CcSEcCtD
Levetiracetam—Paraesthesia—Niacin—atherosclerosis	0.000358	0.00165	CcSEcCtD
Levetiracetam—Feeling abnormal—Simvastatin—atherosclerosis	0.000358	0.00165	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000358	0.00165	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000355	0.00163	CcSEcCtD
Levetiracetam—Insomnia—Pravastatin—atherosclerosis	0.000355	0.00163	CcSEcCtD
Levetiracetam—Somnolence—Niacin—atherosclerosis	0.000354	0.00163	CcSEcCtD
Levetiracetam—Paraesthesia—Pravastatin—atherosclerosis	0.000352	0.00162	CcSEcCtD
Levetiracetam—Dyspepsia—Niacin—atherosclerosis	0.000351	0.00161	CcSEcCtD
Levetiracetam—Decreased appetite—Niacin—atherosclerosis	0.000347	0.00159	CcSEcCtD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000345	0.0123	CbGpPWpGaD
Levetiracetam—Dyspepsia—Pravastatin—atherosclerosis	0.000345	0.00159	CcSEcCtD
Levetiracetam—Rash—Rosuvastatin—atherosclerosis	0.000345	0.00159	CcSEcCtD
Levetiracetam—Dermatitis—Rosuvastatin—atherosclerosis	0.000345	0.00159	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Niacin—atherosclerosis	0.000344	0.00158	CcSEcCtD
Levetiracetam—Body temperature increased—Simvastatin—atherosclerosis	0.000343	0.00158	CcSEcCtD
Levetiracetam—Abdominal pain—Simvastatin—atherosclerosis	0.000343	0.00158	CcSEcCtD
Levetiracetam—Headache—Rosuvastatin—atherosclerosis	0.000343	0.00158	CcSEcCtD
Levetiracetam—Hypersensitivity—Lovastatin—atherosclerosis	0.000342	0.00157	CcSEcCtD
Levetiracetam—Decreased appetite—Pravastatin—atherosclerosis	0.000341	0.00157	CcSEcCtD
Levetiracetam—Pain—Niacin—atherosclerosis	0.000341	0.00157	CcSEcCtD
Levetiracetam—Fatigue—Pravastatin—atherosclerosis	0.000338	0.00156	CcSEcCtD
Levetiracetam—Constipation—Pravastatin—atherosclerosis	0.000336	0.00154	CcSEcCtD
Levetiracetam—Pain—Pravastatin—atherosclerosis	0.000336	0.00154	CcSEcCtD
Levetiracetam—Hypersensitivity—Ezetimibe—atherosclerosis	0.000335	0.00154	CcSEcCtD
Levetiracetam—Asthenia—Lovastatin—atherosclerosis	0.000333	0.00153	CcSEcCtD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—ABCG5—atherosclerosis	0.00033	0.0117	CbGpPWpGaD
Levetiracetam—Pruritus—Lovastatin—atherosclerosis	0.000328	0.00151	CcSEcCtD
Levetiracetam—Asthenia—Ezetimibe—atherosclerosis	0.000327	0.0015	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Niacin—atherosclerosis	0.000326	0.0015	CcSEcCtD
Levetiracetam—Nausea—Rosuvastatin—atherosclerosis	0.000325	0.0015	CcSEcCtD
Levetiracetam—Feeling abnormal—Pravastatin—atherosclerosis	0.000323	0.00149	CcSEcCtD
Levetiracetam—Pruritus—Ezetimibe—atherosclerosis	0.000322	0.00148	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000321	0.00148	CcSEcCtD
Levetiracetam—Hypersensitivity—Simvastatin—atherosclerosis	0.00032	0.00147	CcSEcCtD
Levetiracetam—Diarrhoea—Lovastatin—atherosclerosis	0.000318	0.00146	CcSEcCtD
Levetiracetam—Body temperature increased—Niacin—atherosclerosis	0.000315	0.00145	CcSEcCtD
Levetiracetam—Abdominal pain—Niacin—atherosclerosis	0.000315	0.00145	CcSEcCtD
Levetiracetam—Asthenia—Simvastatin—atherosclerosis	0.000311	0.00143	CcSEcCtD
Levetiracetam—Diarrhoea—Ezetimibe—atherosclerosis	0.000311	0.00143	CcSEcCtD
Levetiracetam—Abdominal pain—Pravastatin—atherosclerosis	0.00031	0.00143	CcSEcCtD
Levetiracetam—Body temperature increased—Pravastatin—atherosclerosis	0.00031	0.00143	CcSEcCtD
Levetiracetam—Pruritus—Simvastatin—atherosclerosis	0.000307	0.00141	CcSEcCtD
Levetiracetam—Dizziness—Lovastatin—atherosclerosis	0.000307	0.00141	CcSEcCtD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000304	0.0108	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000302	0.0108	CbGpPWpGaD
Levetiracetam—Dizziness—Ezetimibe—atherosclerosis	0.000301	0.00139	CcSEcCtD
Levetiracetam—Diarrhoea—Simvastatin—atherosclerosis	0.000297	0.00137	CcSEcCtD
Levetiracetam—Vomiting—Lovastatin—atherosclerosis	0.000295	0.00136	CcSEcCtD
Levetiracetam—Hypersensitivity—Niacin—atherosclerosis	0.000294	0.00135	CcSEcCtD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—atherosclerosis	0.000293	0.0104	CbGpPWpGaD
Levetiracetam—Rash—Lovastatin—atherosclerosis	0.000293	0.00135	CcSEcCtD
Levetiracetam—Dermatitis—Lovastatin—atherosclerosis	0.000292	0.00135	CcSEcCtD
Levetiracetam—SV2A—Disease—APOA4—atherosclerosis	0.000291	0.0104	CbGpPWpGaD
Levetiracetam—Headache—Lovastatin—atherosclerosis	0.000291	0.00134	CcSEcCtD
Levetiracetam—Vomiting—Ezetimibe—atherosclerosis	0.000289	0.00133	CcSEcCtD
Levetiracetam—Hypersensitivity—Pravastatin—atherosclerosis	0.000289	0.00133	CcSEcCtD
Levetiracetam—Dizziness—Simvastatin—atherosclerosis	0.000287	0.00132	CcSEcCtD
Levetiracetam—Rash—Ezetimibe—atherosclerosis	0.000287	0.00132	CcSEcCtD
Levetiracetam—Dermatitis—Ezetimibe—atherosclerosis	0.000287	0.00132	CcSEcCtD
Levetiracetam—Asthenia—Niacin—atherosclerosis	0.000286	0.00132	CcSEcCtD
Levetiracetam—Headache—Ezetimibe—atherosclerosis	0.000285	0.00131	CcSEcCtD
Levetiracetam—Pruritus—Niacin—atherosclerosis	0.000282	0.0013	CcSEcCtD
Levetiracetam—Asthenia—Pravastatin—atherosclerosis	0.000282	0.0013	CcSEcCtD
Levetiracetam—Pruritus—Pravastatin—atherosclerosis	0.000278	0.00128	CcSEcCtD
Levetiracetam—Vomiting—Simvastatin—atherosclerosis	0.000276	0.00127	CcSEcCtD
Levetiracetam—Nausea—Lovastatin—atherosclerosis	0.000276	0.00127	CcSEcCtD
Levetiracetam—Rash—Simvastatin—atherosclerosis	0.000274	0.00126	CcSEcCtD
Levetiracetam—Dermatitis—Simvastatin—atherosclerosis	0.000273	0.00126	CcSEcCtD
Levetiracetam—Diarrhoea—Niacin—atherosclerosis	0.000273	0.00126	CcSEcCtD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000272	0.00969	CbGpPWpGaD
Levetiracetam—Headache—Simvastatin—atherosclerosis	0.000272	0.00125	CcSEcCtD
Levetiracetam—Nausea—Ezetimibe—atherosclerosis	0.00027	0.00124	CcSEcCtD
Levetiracetam—Diarrhoea—Pravastatin—atherosclerosis	0.000269	0.00124	CcSEcCtD
Levetiracetam—Dizziness—Niacin—atherosclerosis	0.000264	0.00121	CcSEcCtD
Levetiracetam—Dizziness—Pravastatin—atherosclerosis	0.00026	0.00119	CcSEcCtD
Levetiracetam—Nausea—Simvastatin—atherosclerosis	0.000258	0.00119	CcSEcCtD
Levetiracetam—Vomiting—Niacin—atherosclerosis	0.000253	0.00117	CcSEcCtD
Levetiracetam—Rash—Niacin—atherosclerosis	0.000251	0.00116	CcSEcCtD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000251	0.00894	CbGpPWpGaD
Levetiracetam—Dermatitis—Niacin—atherosclerosis	0.000251	0.00116	CcSEcCtD
Levetiracetam—SV2A—Disease—APOA2—atherosclerosis	0.00025	0.00892	CbGpPWpGaD
Levetiracetam—Headache—Niacin—atherosclerosis	0.00025	0.00115	CcSEcCtD
Levetiracetam—Vomiting—Pravastatin—atherosclerosis	0.00025	0.00115	CcSEcCtD
Levetiracetam—Rash—Pravastatin—atherosclerosis	0.000247	0.00114	CcSEcCtD
Levetiracetam—Dermatitis—Pravastatin—atherosclerosis	0.000247	0.00114	CcSEcCtD
Levetiracetam—Headache—Pravastatin—atherosclerosis	0.000246	0.00113	CcSEcCtD
Levetiracetam—Nausea—Niacin—atherosclerosis	0.000237	0.00109	CcSEcCtD
Levetiracetam—Nausea—Pravastatin—atherosclerosis	0.000233	0.00107	CcSEcCtD
Levetiracetam—SV2A—Disease—BGN—atherosclerosis	0.000231	0.00824	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—PRKCG—atherosclerosis	0.000231	0.00824	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000206	0.00734	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CST3—atherosclerosis	0.000202	0.00718	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NAMPT—atherosclerosis	0.000191	0.0068	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOC3—atherosclerosis	0.000189	0.00672	CbGpPWpGaD
Levetiracetam—SV2A—Disease—LDLR—atherosclerosis	0.000187	0.00667	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HSPA1B—atherosclerosis	0.000181	0.00645	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NCF1—atherosclerosis	0.000175	0.00624	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CYBA—atherosclerosis	0.000165	0.00587	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PARP1—atherosclerosis	0.000161	0.00575	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000143	0.00509	CbGpPWpGaD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000128	0.00456	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL17A—atherosclerosis	0.000124	0.0044	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000123	0.00439	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOB—atherosclerosis	0.000121	0.00432	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000118	0.00421	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000118	0.0042	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—HMOX1—atherosclerosis	0.000117	0.00417	CbGpPWpGaD
Levetiracetam—SV2A—Disease—LPL—atherosclerosis	0.000116	0.00412	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PRKCG—atherosclerosis	0.000113	0.00401	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD40—atherosclerosis	0.00011	0.0039	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTM1—atherosclerosis	0.000109	0.00389	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—AGER—atherosclerosis	0.000105	0.00375	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MTHFR—atherosclerosis	0.000104	0.00371	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	0.000104	0.0037	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PDGFB—atherosclerosis	0.000102	0.00361	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—AGTR1—atherosclerosis	0.0001	0.00357	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	9.81e-05	0.00349	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOE—atherosclerosis	9.71e-05	0.00346	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CAV1—atherosclerosis	9.62e-05	0.00342	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOA1—atherosclerosis	9.6e-05	0.00342	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—PDGFB—atherosclerosis	9.4e-05	0.00335	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	9.35e-05	0.00333	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS2—atherosclerosis	9.05e-05	0.00322	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	8.47e-05	0.00302	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL10—atherosclerosis	8.4e-05	0.00299	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD40LG—atherosclerosis	8.4e-05	0.00299	CbGpPWpGaD
Levetiracetam—SV2A—Disease—INS—atherosclerosis	8.29e-05	0.00295	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	7.98e-05	0.00284	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—FASLG—atherosclerosis	7.8e-05	0.00278	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	7.62e-05	0.00271	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SERPINE1—atherosclerosis	7.62e-05	0.00271	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	7.43e-05	0.00265	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	7.33e-05	0.00261	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS3—atherosclerosis	7.27e-05	0.00259	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	7.08e-05	0.00252	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTGS2—atherosclerosis	6.65e-05	0.00237	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	6.26e-05	0.00223	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	5.8e-05	0.00206	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	5.56e-05	0.00198	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CETP—atherosclerosis	5.43e-05	0.00193	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	5.37e-05	0.00191	CbGpPWpGaD
Levetiracetam—SV2A—Disease—STAT3—atherosclerosis	5.19e-05	0.00185	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MAPK3—atherosclerosis	4.96e-05	0.00176	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IFNG—atherosclerosis	4.94e-05	0.00176	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TGFB1—atherosclerosis	4.81e-05	0.00171	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.79e-05	0.0017	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	4.59e-05	0.00163	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—TGFB1—atherosclerosis	4.45e-05	0.00159	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL1B—atherosclerosis	4.4e-05	0.00157	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	4.39e-05	0.00156	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	4.32e-05	0.00154	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	4.3e-05	0.00153	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PLG—atherosclerosis	4.07e-05	0.00145	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	3.98e-05	0.00142	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	3.85e-05	0.00137	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.75e-05	0.00134	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	3.73e-05	0.00133	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IL6—atherosclerosis	3.62e-05	0.00129	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—APOB—atherosclerosis	3.6e-05	0.00128	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	3.58e-05	0.00128	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	3.45e-05	0.00123	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	3.42e-05	0.00122	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT1—atherosclerosis	3.34e-05	0.00119	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	3.25e-05	0.00116	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TNF—atherosclerosis	3.2e-05	0.00114	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LDLRAP1—atherosclerosis	3.19e-05	0.00114	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.03e-05	0.00108	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLTP—atherosclerosis	3e-05	0.00107	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.85e-05	0.00101	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	2.82e-05	0.001	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	2.75e-05	0.000978	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LTA4H—atherosclerosis	2.6e-05	0.000927	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCG8—atherosclerosis	2.6e-05	0.000927	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	2.55e-05	0.000909	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	2.34e-05	0.000831	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.25e-05	0.000803	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.25e-05	0.000801	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCG1—atherosclerosis	2.06e-05	0.000733	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.03e-05	0.000722	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.99e-05	0.000709	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FABP4—atherosclerosis	1.94e-05	0.000689	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LCAT—atherosclerosis	1.94e-05	0.000689	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.91e-05	0.000681	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOA4—atherosclerosis	1.9e-05	0.000676	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.87e-05	0.000664	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.84e-05	0.000655	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.77e-05	0.000628	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.74e-05	0.00062	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.72e-05	0.000614	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.69e-05	0.000602	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.69e-05	0.000601	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.64e-05	0.000582	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOA2—atherosclerosis	1.64e-05	0.000582	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALOX15—atherosclerosis	1.64e-05	0.000582	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.64e-05	0.000582	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCG5—atherosclerosis	1.62e-05	0.000575	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.58e-05	0.000561	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LPA—atherosclerosis	1.56e-05	0.000555	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—BGN—atherosclerosis	1.51e-05	0.000538	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOA5—atherosclerosis	1.5e-05	0.000532	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.44e-05	0.000512	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.43e-05	0.000508	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALOX5—atherosclerosis	1.39e-05	0.000495	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.34e-05	0.000476	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NAMPT—atherosclerosis	1.25e-05	0.000444	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LIPC—atherosclerosis	1.24e-05	0.000441	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOC3—atherosclerosis	1.23e-05	0.000438	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LDLR—atherosclerosis	1.22e-05	0.000436	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CETP—atherosclerosis	1.2e-05	0.000426	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.17e-05	0.000418	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SCARB1—atherosclerosis	1.14e-05	0.000408	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HMGCR—atherosclerosis	1.08e-05	0.000385	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.06e-05	0.000377	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCA1—atherosclerosis	9.64e-06	0.000343	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HMOX1—atherosclerosis	8.27e-06	0.000294	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOB—atherosclerosis	7.92e-06	0.000282	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTM1—atherosclerosis	7.7e-06	0.000274	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LPL—atherosclerosis	7.56e-06	0.000269	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPX1—atherosclerosis	7.38e-06	0.000263	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CD36—atherosclerosis	7.19e-06	0.000256	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTHFR—atherosclerosis	6.81e-06	0.000242	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARA—atherosclerosis	6.68e-06	0.000238	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AGT—atherosclerosis	6.47e-06	0.00023	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOE—atherosclerosis	6.34e-06	0.000226	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CAV1—atherosclerosis	6.28e-06	0.000224	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOA1—atherosclerosis	6.27e-06	0.000223	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.72e-06	0.000204	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARG—atherosclerosis	5.52e-06	0.000197	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—INS—atherosclerosis	5.42e-06	0.000193	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALB—atherosclerosis	4.96e-06	0.000177	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NOS3—atherosclerosis	4.75e-06	0.000169	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—atherosclerosis	4.34e-06	0.000155	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKT1—atherosclerosis	2.18e-06	7.77e-05	CbGpPWpGaD
